Search results for "Liver Neoplasms."

showing 10 items of 733 documents

FOCAL LIVER LESIONS: CONTRAST-ENHANCED ULTRASOUND

2008

Contrast-enhanced ultrasound (CEUS) represents a significant breakthrough in sonography and it is being increasingly used for evaluation of focal liver lesions (FLLs). The unique feature of CEUS of non-invasively assessing in real time liver perfusion throughout the vascular phase has led to a dramatic improvement in diagnostic accuracy of US in either detection and characterization of FLLs, as well as in the guidance and evaluation of response of therapeutic procedures. Currently, CEUS is included as a part of the suggested diagnostic work-up of FLLs, resulting in a better patient management and cost-effective therapy delivering. After a brief description of the basis of different CEUS tec…

Echinococcosis HepaticLiver perfusionmedicine.medical_specialtyUrologyLiver AbscessClinical settingsDiagnostic accuracySensitivity and SpecificityLiver neoplasmAdenoma Liver CellLiver diseaseInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingUltrasonography Doppler ColorUltrasound contrast mediaRadiological and Ultrasound TechnologyCystsbusiness.industryLiver DiseasesLiver NeoplasmsUltrasoundGastroenterologyUltrasonography DopplerGeneral MedicineHepatologyImage Enhancementmedicine.diseaseContrast-enhanced sonographyPatient managementFatty LiverFocal Nodular HyperplasiaUltrasonography Doppler PulsedRadiologyLiver sonographyHemangiomabusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaLiver diseaseContrast-enhanced ultrasound
researchProduct

The Co‐mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion‐Driven Cholangiocarcinoma

2021

Background and aims Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer and a highly lethal malignancy. Chemotherapeutic options are limited, but a considerable subset of patients harbors genetic lesions for which targeted agents exist. Fibroblast growth factor receptor 2 (FGFR2) fusions belong to the most frequent and therapeutically relevant alterations in ICC, and the first FGFR inhibitor was recently approved for the treatment of patients with progressed, fusion-positive ICC. Response rates of up to 35% indicate that FGFR-targeted therapies are beneficial in many but not all patients. Thus far, no established biomarkers exist that predict resistance or r…

Fetal Proteins0301 basic medicineAntimetabolites AntineoplasticCombination therapymedicine.medical_treatmentFGFR InhibitionVesicular Transport ProteinsCyclic AMP Response Element-Binding Protein Amedicine.disease_causeDeoxycytidineMalignant transformationTargeted therapyCholangiocarcinomaProto-Oncogene Proteins p21(ras)Mice03 medical and health sciencesLiver Neoplasms Experimental0302 clinical medicineAntigens NeoplasmmedicineAnimalsReceptor Fibroblast Growth Factor Type 2Protein Kinase InhibitorsCell ProliferationHepatologyOncogenebusiness.industryFibroblast growth factor receptor 2AdenosylhomocysteinasePhenylurea CompoundsGemcitabineBile Ducts IntrahepaticCell Transformation NeoplasticPyrimidines030104 developmental biologyBile Duct NeoplasmsFibroblast growth factor receptorMutationCancer research030211 gastroenterology & hepatologyKRASGene FusionbusinessCo-Repressor ProteinsMicrotubule-Associated ProteinsHepatology
researchProduct

Apoptosis induced in hepatoblastoma HepG2 cells by the proteasome inhibitor MG132 is associated with hydrogen peroxide production, expression of Bcl-…

2002

This report is focused on the apoptotic effect induced by MG132, an inhibitor of 26S proteasome, in human hepatoma HepG2 cells. The results were compared with those obtained with non-transformed human Chang liver cells. MG132 reduced the viability of HepG2 cells in a time- and dose-dependent manner. The effect was in tight connection with the induction of apoptosis, as indicated by fluorescence microscopy and cytometric analysis, and was accompanied by a remarkable increase in the production of H2O2 and a reduction in mitochondrial transmembrane potential (Deltapsim). In addition cell death was prevented by antioxidants such as GSH, N-acetylcysteine or catalase. Western blot analysis showed…

G2 PhaseHepatoblastomaCancer ResearchProgrammed cell deathProteasome Endopeptidase ComplexMG132Time FactorsCell SurvivalLeupeptinsPoly ADP ribose polymeraseBlotting Westernbcl-X ProteinMitosisCaspase 3Antineoplastic AgentsApoptosismacromolecular substancesMembrane Potentialschemistry.chemical_compoundCytosolMultienzyme ComplexesMG132medicineTumor Cells CulturedHumansCaspasebiologyCaspase 3Cytochrome cCell CycleLiver NeoplasmsHydrogen PeroxideFlow CytometryMolecular biologyMitochondriaEnzyme ActivationCysteine EndopeptidasesOxidative StressOncologyBiochemistrychemistryProto-Oncogene Proteins c-bcl-2ApoptosisCaspasesbiology.proteinProteasome inhibitormedicine.drug
researchProduct

Comparison of the chemopreventive efficacies of garlic powders with different alliin contents against aflatoxin B1 carcinogenicity in rats

2004

Garlic (Allium sativum) is well known for its beneficial effects on health and particularly for its chemopreventive potential against cancer. The present study was designed to compare the chemopreventive efficacies of several garlic powders with various levels of alliin, a precursor of active sulfur compounds. For this purpose we used the medium-term hepatocarcinogenesis protocol (resistant hepatocyte model), which allows the detection of preneoplasic foci expressing the placental form of glutathione S-transferase (GST-P) as an end-point. Rats were fed diets containing three garlic powders (5% of the diet) with various alliin contents for 3 weeks. Garlic powders were obtained from bulbs gro…

GARLIC POWDERMale[SDE] Environmental SciencesCancer ResearchAflatoxinAflatoxin B1[SDV]Life Sciences [q-bio]Antineoplastic AgentsAlliinChemoprevention03 medical and health scienceschemistry.chemical_compound0302 clinical medicinefoodLiver Neoplasms ExperimentalCytochrome P-450 CYP1A1IngestionAnimalsFood scienceCysteineGlucuronosyltransferaseRats WistarGarlicAnticarcinogenCarcinogenComputingMilieux_MISCELLANEOUS030304 developmental biologyGlutathione Transferase2. Zero hunger0303 health sciencesfood and beveragesGeneral MedicineGlutathioneAllium sativumCANCERfood.food3. Good healthDietRats[SDV] Life Sciences [q-bio]chemistryBiochemistry030220 oncology & carcinogenesis[SDE]Environmental SciencesRATPowdersCARCINOGENESEPrecancerous Conditions
researchProduct

Outcome of LR-3 and LR-4 observations without arterial phase hyperenhancement at Gd-EOB-DTPA-enhanced MRI follow-up

2020

Objective: The aim of this study was to retrospectively analyze the outcome of LR-3 and LR-4 without arterial phase hyperenhancement (APHE), and identify which features could predict LR-5 progression on serial Gd-EOB-DTPA-enhanced MRI follow-up. Methods: Forty-nine cirrhotic patients with 55 LR-3 and 19 LR-4 without APHE were evaluated. Observations were classified as decreased, stable or increased in category at follow-up. Observation size and LI-RADS major and ancillary features were evaluated. Results: Seventeen/fifty-five (31%) LR-3 and 8/19 (42%) LR-4 progressed to LR-5 at follow-up. Baseline LI-RADS major and ancillary features were not significantly different among LR-3 and LR-4. A d…

Gadolinium DTPAGd-EOB-DTPA-enhanced MRILR-3Carcinoma HepatocellularLR-4business.industryLiver NeoplasmsGd-EOB-DTPAContrast MediaMagnetic Resonance Imaging030218 nuclear medicine & medical imagingSettore MED/01 - Statistica Medica03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisMedicineHumansLI-RADSRadiology Nuclear Medicine and imagingNuclear medicinebusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaArterial phaseFollow-Up StudiesRetrospective Studies
researchProduct

Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.

2015

Gadoxetic acid improves detection and characterization of focal liver lesions in cirrhotic patients and can estimate liver function in patients undergoing liver resection. The purpose of this article is to describe the optimal gadoxetic acid study protocol for the liver, the unique characteristics of gadoxetic acid, the differences between gadoxetic acid and extra-cellular gadolium chelates, and the differences in phases of enhancement between cirrhotic and normal liver using gadoxetic acid. We also discuss how to obtain and recognize an adequate hepatobiliary phase.

Gadolinium DTPALiver CirrhosisGadoxetic acidCirrhotic livermedicine.medical_specialtySettore MED/09 - Medicina InternaCirrhosisCarcinoma HepatocellularGadoxetic acidContrast MediaGastroenterology030218 nuclear medicine & medical imagingResection03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumansIn patientTopic HighlightSettore MED/12 - GastroenterologiaCirrhosimedicine.diagnostic_testbusiness.industryLiver NeoplasmsGastroenterologyHepatobiliary contrast materialMagnetic resonance imagingGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingSettore MED/18 - Chirurgia GeneraleLiver030220 oncology & carcinogenesisHepatobiliary phaseLiver functionSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessCirrhosis; Gadoxetic acid; Hepatobiliary contrast materials; Liver; Magnetic resonance imaging; Gastroenterologymedicine.drugWorld journal of gastroenterology
researchProduct

MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.

2016

Purpose: The purpose of the study is to compare the MR-imaging features of hepatocellular carcinoma (HCC) capsule appearance on gadoxetic acid and gadobenate dimeglumine-enhanced MR imaging, using imaging-based presumptive diagnosis of HCC as the reference standard. Methods: Gadoxetic acid and gadobenate dimeglumine-enhanced MR imaging of 51 patients with 71 HCCs were retrospectively reviewed. Three readers graded in consensus, using a five-point scale, the presence (score 4–5) of capsule appearance on images obtained during T1-weighted GRE portal venous phase (PVP), 3-min phase, and hepatobiliary phase (HBP). The Fisher's exact test and the t student unpaired test were performed. Results: …

Gadolinium DTPALiver CirrhosisMaleCirrhotic livermedicine.medical_specialtyGadoxetic acidCarcinoma HepatocellularHepatocellular carcinomaUrologyGadoxetic acidContrast MediaSensitivity and Specificity030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineMeglumineInternal medicineGadobenate dimegluminemedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingGADOBENATE DIMEGLUMINECapsuleAgedRetrospective StudiesAged 80 and overRadiological and Ultrasound Technologybusiness.industryLiver NeoplasmsGastroenterologyCapsuleReproducibility of ResultsHepatologyHCCSMiddle Agedmedicine.diseaseImage EnhancementMr imagingMagnetic Resonance Imagingdigestive system diseasesLiver030220 oncology & carcinogenesisHepatocellular carcinomaFemaleRadiologybusinessMR imagingmedicine.drugAbdominal radiology (New York)
researchProduct

Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging

2021

Abstract Objectives The 9th International Forum for Liver Magnetic Resonance Imaging (MRI) was held in Singapore in September 2019, bringing together radiologists and allied specialists to discuss the latest developments in and formulate consensus statements for liver MRI, including the applications of gadoxetic acid–enhanced imaging. Methods As at previous Liver Forums, the meeting was held over 2 days. Presentations by the faculty on days 1 and 2 and breakout group discussions on day 1 were followed by delegate voting on consensus statements presented on day 2. Presentations and discussions centered on two main meeting themes relating to the use of gadoxetic acid–enhanced MRI in primary l…

Gadolinium DTPAMagnetic Resonance SpectroscopyHepatocellular carcinomaGadoxetic acidContrast MediaOral and gastrointestinal030218 nuclear medicine & medical imagingLiver disease0302 clinical medicineCancerNeuroradiologymedicine.diagnostic_testLiver DiseaseLiver NeoplasmsInterventional radiologyGeneral MedicineMetastatic liver diseaseNuclear Medicine & Medical Imaging030220 oncology & carcinogenesisBiomedical ImagingRadiologymedicine.symptomPrimary liver cancerAfter treatmentmedicine.drugLiver Cancermedicine.medical_specialtyGadoxetic acidCarcinoma HepatocellularConsensusChronic Liver Disease and CirrhosisClinical SciencesSensitivity and Specificity03 medical and health sciencesMagnetic resonance imagingRare DiseasesmedicineHumansRadiology Nuclear Medicine and imagingRetrospective Studiesbusiness.industryCarcinomaHepatocellularMetastatic liver diseaseMagnetic resonance imagingmedicine.diseaseOrphan DrugDigestive DiseasesbusinessEuropean Radiology
researchProduct

Enhancing capsule in hepatocellular carcinoma: intra-individual comparison between CT and MRI with extracellular contrast agent

2021

Purpose: The purpose of this study was to compare the value of contrast-enhanced computed tomography (CT) to that of magnetic resonance imaging obtained with extracellular contrast agent (ECA-MRI) for the diagnosis of a tumor capsule in hepatocellular carcinoma (HCC) using histopathologic findings as the standard of reference. Materials and methods: This retrospective study included patients with pathologically-proven resected HCCs with available preoperative contrast-enhanced CT and ECA-MRI examinations. Two blinded radiologists independently reviewed contrast-enhanced CT and ECA-MRI examinations to assess the presence of an enhancing capsule. The histopathological analysis of resected spe…

Gadolinium DTPAMaleCarcinoma HepatocellularContrast MediaComputed tomographySensitivity and SpecificityMcNemar's testExtracellularmedicineHumansRadiology Nuclear Medicine and imagingCapsule Computed tomography Extracellular contrast agent Hepatocellular carcinoma Magnetic resonance imagingAgedRetrospective StudiesRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryLiver NeoplasmsCapsuleMagnetic resonance imagingRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance ImagingHepatocellular carcinomaFemaleTomography X-Ray ComputedSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessNuclear medicineKappaDiagnostic and Interventional Imaging
researchProduct

Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: Outcome and rate of hypervascular transformation.

2019

Purpose: To investigate the clinical implications and natural history of observations showing a “nodule-in-nodule” architecture on hepatobiliary phase (HBP) in a cirrhotic population. Method: This is an IRB-approved retrospective study conducted in a single institution. We identified 20 patients (11 men and 9 women, mean age 71 years, range 51–83 years) who had a hyperintense nodule on HBP arising within a larger HBP-hypointense nodule without arterial phase hyperenhancement (APHE) at gadoxetate disodium-enhanced MRI. Size and signal intensity of the nodules were evaluated in all sequences, along with the evolution of the nodules at serial MRI studies. Results: Twenty-four…

Gadolinium DTPAMaleCarcinoma HepatocellularHepatocellular carcinomaPopulationContrast MediaNodule-in-nodule030218 nuclear medicine & medical imagingHepatobiliary phaseGadoxetate Disodium03 medical and health sciences0302 clinical medicineMedicineHumansRadiology Nuclear Medicine and imagingeducationAgedRetrospective StudiesAged 80 and overeducation.field_of_studymedicine.diagnostic_testbusiness.industryLiver NeoplasmsWashoutMagnetic resonance imagingNodule (medicine)General MedicineMiddle Agedmedicine.diseaseImage EnhancementMagnetic Resonance ImagingHyperintensityLiver Neoplasm030220 oncology & carcinogenesisHepatocellular carcinomaHepatobiliary phaseFemaleGadoxetate disodiummedicine.symptombusinessNuclear medicineHumanEuropean journal of radiology
researchProduct